|
Market Closed -
Swiss Exchange
00:30:30 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 133.78 CHF | +1.12% |
|
+3.80% | +22.06% |
| 10-30 | HEALTH ROUNDS-Rise in US colon cancer rates not limited to young adults, analysis finds | RE |
| 10-30 | Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge | RE |
| Market Cap | 307B 275B 253B 229B 429B 29,118B 436B 3,010B 1,209B 15,314B 1,151B 1,126B 48,311B | P/E 2026 * |
23.2x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 342B 307B 282B 256B 478B 32,501B 487B 3,359B 1,350B 17,093B 1,285B 1,257B 53,923B | EV / Sales 2026 * |
5.97x | EV / Sales 2027 * | 5.45x |
| Free-Float |
91.66% | Yield 2026 * |
2.71% | Yield 2027 * | 2.83% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
London S.E.
| 0QLR | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Xetra
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
OTC Markets
| NVSEF | Delayed | |
|
Börse Stuttgart
| NOT | Delayed | |
|
CBOE
| Real-time | ||
|
Boerse Muenchen
| NOT | Real-time | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +1.12% | ||
| 1 week | +3.80% | ||
| Current month | +11.52% | ||
| 1 month | +10.64% | ||
| 3 months | +3.11% | ||
| 6 months | +18.03% | ||
| Current year | +22.06% |
| 1 week | 125.38 |  | 135.06 |
| 1 month | 115.94 | | 135.06 |
| Current year | 107.68 | | 135.06 |
| 1 year | 98.61 | | 135.06 |
| 3 years | 81.1 | | 135.06 |
| 5 years | 72.84 | | 135.06 |
| 10 years | 65.09 | | 135.06 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/5/26 | Sell | -5,200 | 0.0003% | |||
| 4/5/26 | Sell | 6,800 | 0.0003% | |||
| 17/2/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | +3.80% | +35.82% | +59.72% | 302B | |
| +3.19% | +8.48% | +74.25% | +153.03% | 1,224B | |
| -0.73% | +2.09% | +46.41% | +87.64% | 662B | |
| +1.41% | +3.40% | +30.98% | +112.26% | 514B | |
| +0.42% | +2.88% | +54.92% | +69.67% | 388B | |
| +2.18% | +1.55% | +72.70% | +45.42% | 361B | |
| +6.96% | +7.55% | +11.15% | +37.89% | 271B | |
| +1.15% | +4.19% | +59.72% | +78.16% | 249B | |
| +3.06% | +8.58% | +44.03% | +122.76% | 205B | |
| +2.21% | +0.51% | -20.53% | -59.69% | 172B | |
| Average | +1.90% | +2.17% | +40.94% | +70.69% | 434.88B | |
| Weighted average by Cap. | +1.32% | +2.85% | +50.43% | +94.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.38B 51.43B 47.34B 42.85B 80.18B 5,448B 81.63B 563B 226B 2,865B 215B 211B 9,039B | 61.5B 55.13B 50.73B 45.93B 85.94B 5,839B 87.49B 604B 243B 3,071B 231B 226B 9,688B |
| Net income | 13.77B 12.34B 11.36B 10.28B 19.24B 1,307B 19.59B 135B 54.3B 688B 51.67B 50.57B 2,169B | 15.98B 14.32B 13.18B 11.93B 22.32B 1,517B 22.73B 157B 63B 798B 59.95B 58.67B 2,517B |
| Net Debt | 35.63B 31.94B 29.39B 26.61B 49.79B 3,383B 50.69B 350B 141B 1,779B 134B 131B 5,613B | 28.51B 25.55B 23.52B 21.29B 39.84B 2,707B 40.55B 280B 112B 1,423B 107B 105B 4,491B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CHF 133.78 | +1.12% | 4,480,157 |
| 29/10/26 | CHF 132.30 | +2.38% | 6,118,905 |
| 28/10/26 | CHF 129.22 | +0.34% | 2,941,763 |
| 27/10/26 | CHF 128.78 | +1.02% | 5,166,869 |
| 26/10/26 | CHF 127.48 | -0.41% | 3,433,560 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
